Buprenorphine is used in medication-assisted treatment to help people reduce or quit their use of heroin or other opiates. Buprenorphine is permitted to be prescribed or dispensed in physician offices, significantly increasing treatment access.
Buprenorphine is a partial opioid agonist. At low doses Buprenorphine produces sufficient agonist effect to enable opioid-addicted individuals to discontinue the misuse of opioids without experiencing withdrawal symptoms. At the appropriate dose, treatment may decrease cravings for opioids, block the effects of other opioids, and help patients stay in treatment.
The first half of the NM training is taken online and the second half is completed in person. The online portion must be completed before the live course on August 19th.
Register at http://www.cvent.com/Surveys/Welcome.aspx?s=d1fe7c94-224d-4d93-b314-baba4f7ad1f9 or email Justina@aaap.org.
Upon registration, you will receive a link to the online portion of the course to be completed prior to the face-to-face portion.
The face-to-face portion will be held on August 19th from 1:00 – 5:00 p.m. at the Sandia Resort in Albuquerque, NM. There is no charge for this important educational offering.
New Mexico Medical Society is the professional organization for medical and osteopathic doctors in the state. www.nmms.org
Funding for this initiative was made possible (in part) by Providers' Clinical Support System for Medication Assisted Treatment (5U79T1024697) from SAMSHA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the US Government.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-mexico-medical-society-helps-break-the-opioid-abuse-cycle-300302860.html
SOURCE New Mexico Medical Society